Kovelman Harry sold $32K of MYO
Kovelman Harry (Chief Medical Officer) sold 32,000 shares of MYOMO, INC. (MYO) at an average of $1.01 ($1.00–$1.02) across 2 trades over 2026-05-27 to 2026-05-28.
How this was made
The 30-second read
Why it matters
It reports an open-market sale by the Chief Medical Officer, totaling $32,239.35 across two trades, with holdings after the sale of 108,618 shares.
Market read
Traders may monitor for sentiment effects from insider selling, but the filing alone does not provide a new fundamental catalyst.
What to watch
The article does not state tax, option exercise context, or whether other insiders are buying; it also provides no 10b5-1 plan details, which can affect interpretation of intent.
Background
The article is a SEC Form 4 insider transaction report for MYOMO, Inc. (MYO).
Ticker impact
MYOMO CMO Harry Kovelman sold 32,000 shares in open-market transactions at about $1.00 to $1.02, per a fresh Form 4 filing.
Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.
This is a routine insider sale disclosure with no 10b5-1 plan and no accompanying company-specific news (earnings, guidance, contracts, or regulatory actions).
Market effects
No sector-level implications are provided; the disclosure is company-specific and limited to an insider transaction.
None indicated.
None indicated.
Counterpoint
Insider sales can be for diversification or liquidity needs and do not necessarily signal deteriorating business prospects, especially without any accompanying negative company event in the filing.
Key entities
- issuerMYOMO, Inc.
Company whose insider sale is disclosed via Form 4.
- insiderHarry Kovelman
Chief Medical Officer who sold 32,000 shares.
